<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2025-11-12</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2025-11-12</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>94</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>5</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ“° å…¬ä¼—å·</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
QIAGEN 2.25äº¿ç¾å…ƒæŠ•å…¥ï¼Œå‘å¸ƒé¦–ä¸ªæ·±åº¦èåˆç©ºé—´ç»„å­¦ä¸å•ç»†èƒç»„å­¦çš„åŸºç¡€æ¨¡å‹ï¼Œå¼€å¯å•ç»†èƒAIé©±åŠ¨æ–°æ—¶ä»£ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- è‚¿ç˜¤å¾®ç¯å¢ƒä¸å…ç–«æ²»ç–—è€è¯æœºåˆ¶ç ”ç©¶ï¼ˆå¦‚è‚¾ç™Œã€Mantle cell lymphomaã€è‚ºç™Œï¼‰ã€‚<br />
- å¤šç»„å­¦ï¼ˆå•ç»†èƒã€ç©ºé—´ç»„å­¦ã€åŸºå› ç»„ã€ä»£è°¢ç»„ï¼‰è”åˆåˆ†æä¸æœºå™¨å­¦ä¹ åœ¨è‚¿ç˜¤åŠå…¶ä»–ç–¾ç—…ï¼ˆè‚¥èƒ–ï¼‰ä¸­çš„åº”ç”¨ã€‚<br />
- ä»£è°¢é€šè·¯ä¸ç–¾ç—…å‘ç”Ÿå‘å±•çš„å…³ç³»ï¼ˆå¦‚ç»´ç”Ÿç´ ä¸ç™Œç—‡ã€è‚ç™Œèµ·æºã€æ¶ˆåŒ–ç³»ç»Ÿä»£è°¢ï¼‰ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- ç©ºé—´è½¬å½•ç»„ä¸å•ç»†èƒè”åˆåˆ†æï¼Œå®ç°åŠŸèƒ½åŸºå› ç»„å­¦ä¸å¾®ç¯å¢ƒæ·±åº¦è§£æã€‚<br />
- AIé©±åŠ¨çš„åŸºç¡€æ¨¡å‹ï¼Œæ•´åˆå¤šç»„å­¦æ•°æ®ï¼Œèµ‹èƒ½å•ç»†èƒç ”ç©¶ã€‚<br />
- æ¶ˆèæœ¯è”åˆå…ç–«ç–—æ³•åœ¨æ™šæœŸè‚ºç™Œæ²»ç–—ä¸­å–å¾—æ˜¾è‘—çªç ´ã€‚</p>
<h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
3DæŸ“è‰²è´¨å›¾è°±è·¨è¶Š57ç§äººç±»ç»†èƒç±»å‹ï¼Œæ­ç¤ºäº†è‡ªèº«å…ç–«æ€§ç–¾ç—…æ˜“æ„Ÿæ€§çš„ç»†èƒå’Œé—ä¼ ç»“æ„ï¼›å•ç»†èƒå¤šç»„å­¦æŠ€æœ¯æ¡†æ¶å®ç°äº†è¡¨è§‚åŸºå› ç»„åŠ¨åŠ›å­¦çš„é‡æ„ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- <strong>ç–¾ç—…æœºåˆ¶æ¢ç´¢</strong>ï¼šåˆ©ç”¨å•ç»†èƒæµ‹åºæŠ€æœ¯ï¼Œæ·±å…¥ç ”ç©¶é’å…‰çœ¼æ¨¡å‹ä¸­çš„çº¿ç²’ä½“åŠŸèƒ½éšœç¢ã€è‚ºç‚æ¨¡å‹ä¸­çš„å¹´é¾„ä¾èµ–æ€§å…ç–«ååº”ã€ä»¥åŠç™Œç—‡ï¼ˆå¦‚åµå·¢ç™Œã€è‚ç™Œã€å®«é¢ˆç™Œï¼‰ä¸­çš„å…ç–«å¾®ç¯å¢ƒé‡å¡‘å’Œæ²»ç–—å“åº”ã€‚<br />
- <strong>é—ä¼ å­¦ä¸ç–¾ç—…å…³è”</strong>ï¼šé€šè¿‡3DæŸ“è‰²è´¨äº’ä½œå›¾è°±ï¼Œè§£æè‡ªèº«å…ç–«æ€§ç–¾ç—…çš„é—ä¼ åŸºç¡€å’Œç»†èƒç‰¹å¼‚æ€§è°ƒæ§æœºåˆ¶ã€‚<br />
- <strong>è¯ç‰©å¼€å‘ä¸è¯„ä¼°</strong>ï¼šè¯„ä¼°æ”¾å°„æ€§è¯ç‰©è”åˆå…ç–«æ£€æŸ¥ç‚¹é˜»æ–­æ²»ç–—åœ¨è‚¿ç˜¤å…ç–«ä¸­çš„åºåˆ—æ•ˆåº”ï¼›ç ”ç©¶é…ªæ°¨é…¸æ¿€é…¶æŠ‘åˆ¶å‰‚ï¼ˆTKIï¼‰çš„å¿ƒè„æ¯’æ€§åŠå…¶é˜²æŠ¤æœºåˆ¶ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- <strong>å¤šç»„å­¦æ•´åˆ</strong>ï¼šç»“åˆRNA-seqã€ATAC-seqã€Hi-Cã€snMultiomeç­‰å¤šç§é«˜é€šé‡æµ‹åºæŠ€æœ¯ï¼Œå®ç°å¯¹åŸºå› ç»„ã€è½¬å½•ç»„å’Œè¡¨è§‚åŸºå› ç»„çš„å…¨é¢è§£æã€‚<br />
- <strong>å•ç»†èƒåˆ†è¾¨ç‡</strong>ï¼šåˆ©ç”¨å•ç»†èƒRNAæµ‹åºï¼ˆscRNA-seqï¼‰ç­‰æŠ€æœ¯ï¼Œå‰–æå¤æ‚ç”Ÿç‰©ç³»ç»Ÿä¸­çš„ç»†èƒå¼‚è´¨æ€§å’ŒåŠ¨æ€å˜åŒ–ã€‚</p>
<h3>ğŸ”¬ æœŸåˆŠæ–‡ç« </h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
æ›²å¦¥ç å•æŠ— Deruxtecan (T-DXd) æ²»ç–—ä¹³è…ºç™Œè€è¯æœºåˆ¶è¢«é˜æ˜ï¼Œå‘ç° HER2 è¡¨è¾¾å’Œç»“åˆçš„æ˜¾è‘—ä¸‹é™æ˜¯å…³é”®åŸå› ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- æ¢ç´¢ä¸åŒç±»å‹ç³–å°¿ç—…ä¸èƒ°è…ºå¯¼ç®¡è…ºç™Œ (PDAC) é£é™©çš„é—ä¼ å…³è”ã€‚<br />
- ä¼˜åŒ–éª¨é«“ç˜¤è¯ç‰©å¼€å‘ï¼Œè¯†åˆ«æé«˜éšæœºå¯¹ç…§è¯•éªŒ (RCT) æˆåŠŸç‡çš„å› ç´ ã€‚<br />
- æ”¹è¿›å¤´é¢ˆéƒ¨é³çŠ¶ç»†èƒç™Œ (HNSCC) æ–°è¾…åŠ©å…ç–«æ²»ç–—çš„ç–—æ•ˆã€‚<br />
- é‡æ–°å®šä¹‰å†œæ‘ç™Œç—‡å·®å¼‚çš„ç ”ç©¶æ–¹æ³•ï¼Œçº³å…¥èº«ä»½å’Œç¤¾åŒºå‚ä¸ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- è¿ç”¨å­Ÿå¾·å°”éšæœºåŒ–å’Œé€šè·¯/åŸºå› é›†åˆ†æç ”ç©¶ç³–å°¿ç—…ä¸ PDAC å…³è”ã€‚<br />
- é€šè¿‡å¯¹ T-DXd æ²»ç–—å‰åé…å¯¹æ‚£è€…æ ‡æœ¬çš„åˆ†å­è¡¨å¾ï¼Œæ­ç¤ºè€è¯æœºåˆ¶ã€‚</p>
<h3>ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
æ¢ç´¢åœ†å‘¨ç‡ï¼ˆPiï¼‰ä¸­éšè—çš„æ— é™å¯èƒ½æ€§ï¼Œé€šè¿‡Rè¯­è¨€å‡½æ•°å®ç°å¯¹ä»»æ„æ•°å­—ä¸²åœ¨Piä¸­çš„æŸ¥æ‰¾ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- åˆ©ç”¨Rè¯­è¨€å‡½æ•°åœ¨åœ†å‘¨ç‡çš„æ— é™åºåˆ—ä¸­æŸ¥æ‰¾ç‰¹å®šæ•°å­—ç»„åˆã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- å¼€å‘äº†ç”¨äºé«˜æ•ˆæ£€ç´¢Piä¸­å­ä¸²çš„Rè¯­è¨€å‡½æ•°ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
RNAæµ‹åºæŠ€æœ¯åœ¨æ­ç¤ºç”Ÿç‰©å­¦å·®å¼‚ä¸ç–¾ç—…æœºåˆ¶æ–¹é¢å–å¾—çªç ´ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- è¯†åˆ«RNAå‰ªæ¥å˜åŒ–ï¼Œå¹¶é‡åŒ–å…¶å—å¹´é¾„ã€æ€§åˆ«ç­‰åå˜é‡çš„å½±å“ã€‚<br />
- æ¢ç©¶å¥³æ€§å’Œç”·æ€§åœ¨é•¿æ–°å† ï¼ˆlong COVIDï¼‰ä¸­å…ç–«ã€æ¿€ç´ åŠä»£è°¢å·®å¼‚ï¼Œè§£é‡Šç—‡çŠ¶ä¸¥é‡ç¨‹åº¦çš„æ€§åˆ«å·®å¼‚ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- å¼€å‘äº†MntJULiPå’ŒJutilså·¥å…·ï¼Œç”¨äºç²¾ç¡®åˆ†æRNAæµ‹åºæ•°æ®ä¸­çš„å·®å¼‚å‰ªæ¥ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“° å…¬ä¼—å· (20æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>QIAGENè±ªæ·2.25äº¿ç¾å…ƒå¼€å¯å•ç»†èƒAIé©±åŠ¨æ–°æ—¶ä»£ï¼›é¦–ä¸ªå°†ç©ºé—´ç»„å­¦ä¸å•ç»†èƒç»„å­¦æ·±åº¦èåˆçš„åŸºç¡€æ¨¡å‹ï¼›è‚¾ç™Œå…ç–«ç–—æ³•è€è¯æ–°æœºåˆ¶ç­‰</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå•ç»†èƒå¤©åœ°<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€è€è¯ã€å•ç»†èƒã€ç©ºé—´ç»„å­¦<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI1Njk4ODE0MQ==&amp;mid=2247533611&amp;idx=1&amp;sn=f53e163cc8b279c6234644ed113667f0" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>åŸºå› ç»„+ç©ºé—´ç»„--åŠŸèƒ½åŸºå› ç»„å­¦ä¸è‚¿ç˜¤å¾®ç¯å¢ƒåˆ†ææ­ç¤ºMantle  cell lymphomaçš„é¢„åç”Ÿç‰©å­¦äºšå‹</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå•ç»†èƒç©ºé—´äº¤å“ä¹<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€lymphomaã€ç©ºé—´ç»„å­¦ã€åŸºå› ç»„<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šåŸºå› ç»„+ç©ºé—´ç»„--åŠŸèƒ½åŸºå› ç»„å­¦ä¸è‚¿ç˜¤å¾®ç¯å¢ƒåˆ†ææ­ç¤ºMantle cell lymphomaçš„é¢„åç”Ÿç‰©å­¦äºšå‹<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2MDY1NTYyOQ==&amp;mid=2247498859&amp;idx=1&amp;sn=62df1cebc4d6545cbe416742993efc88" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>ç©ºé—´è½¬å½•ç»„+å•ç»†èƒè”åˆåˆ†æï¼Œè¿™ç¯‡æ–°å† è‚ºæŸä¼¤ç ”ç©¶æ­ç¤ºSPP1ä¿¡å·ä¿ƒè¿›çº¤æº¶å…³é—­ï¼Œåˆ†ææµç¨‹å¯ç›´æ¥å¥—ç”¨å…¶ä»–çº¤ç»´åŒ–ç–¾ç—…ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°åšå£«<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒã€ç©ºé—´è½¬å½•ç»„ã€è½¬å½•ç»„<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2NDcxMzYwNg==&amp;mid=2247490515&amp;idx=1&amp;sn=3d28bd2eaa98cee6267b0dcfc43cd49e" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>æœ€æ–°8.5åˆ†å•åŸºå› ç”Ÿä¿¡ï¼Œæ³›ç™Œ+å•ç»†èƒ+ç©ºè½¬+éªŒè¯ï¼Œå¤šç»„å­¦åˆ†æä¸€èµ·ä¸Šåˆ†ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒã€åŸºå› ç»„ã€ç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503930&amp;idx=2&amp;sn=ebe229227a93f9635bf12b876a4a8475" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> <strong>å•ç»†èƒè½¬å½•ç»„å­¦åˆ†ææ­ç¤ºé£Ÿç®¡å°ç»†èƒç™Œçš„ä¸Šçš®å’Œå¾®ç¯å¢ƒå¼‚è´¨æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡èœé¸Ÿå›¢<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒã€è½¬å½•ç»„<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzUzMTEwODk0Ng==&amp;mid=2247537963&amp;idx=1&amp;sn=f397b62fcee5ade8c48023df4cb63cac" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> <strong>æœ€æ–°7.5åˆ†ç”Ÿä¿¡ï¼Œå¤šç»„å­¦ç»“åˆæœºå™¨å­¦ä¹ ç­›é€‰è‚¥èƒ–ç›¸å…³çš„å…³é”®åŸºå› å¹¶éªŒè¯ï¼Œéè‚¿ç˜¤ç»å…¸æ€è·¯ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503930&amp;idx=1&amp;sn=fc668c98b03e36dbe94716c050c88679" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>è¿™ç§å¸¸è§ç»´ç”Ÿç´ ï¼Œç«Ÿä¸ä¿ƒè¿›ç™Œç—‡ç”Ÿé•¿æœ‰å…³ï¼ç ”ç©¶å‘ç°ï¼šå‡å°‘æ‘„å…¥å³å¯é˜»æ­¢å°é¼ è‚¿ç˜¤ç”Ÿé•¿</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šä¸é¦™å­¦æœ¯<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç™Œç—‡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šå¤šé¡¹ç ”ç©¶å†æ·»æ–°è¯ï¼<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247649831&amp;idx=1&amp;sn=ff35bf3dfb08116d6ecc25ae99363175" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>ä»£è°¢é…¶çš„â€œéç»å…¸â€æœºåˆ¶â€”è¡¨è§‚é‡ç¼–ç¨‹ï¼Œçœ‹æ‡‚è¿™ç¯‡Cell Metabolismè¿˜ç¼ºå‘é¡¶åˆŠçš„æ€è·¯å—ï¼Ÿ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå°å¼ èŠç§‘ç ”<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šä»£è°¢ã€metabolism<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šè¯¾é¢˜å’Œæ–‡ç« æ€è·¯è¯·è”ç³»Alice@è§£é¢ç”Ÿç‰©,æ‰«ç å¤‡æ³¨ï¼šç§‘ç ”æœåŠ¡<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655821349&amp;idx=4&amp;sn=2e0db14abef1602510e139f90fe67668" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>BD Rhapsodyå•ç»†èƒåŸºå› è¡¨è¾¾å®šé‡</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šseqyuan<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒ<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šBD Rhapsodyä¸Šæ¸¸åˆ†æï¼Œå•ç»†èƒåŸºå› è¡¨è¾¾å®šé‡<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzU1MDMyNzUyNQ==&amp;mid=2247484726&amp;idx=1&amp;sn=a0cfd119672edfdc4afc206e3fea9711" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>è¯¦è§£ï¼šäººä½“æ¶ˆåŒ–ç³»ç»Ÿçš„ç‰©è´¨ä»£è°¢è¿‡ç¨‹</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå°æä»£è°¢<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šä»£è°¢<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šäººä½“æ¶ˆåŒ–ç³»ç»Ÿæ˜¯ä¸€ä¸ªå¤æ‚è€Œé«˜æ•ˆçš„ä½“ç³»ï¼Œé€šè¿‡æœºæ¢°å’ŒåŒ–å­¦çš„ååŒä½œç”¨ï¼Œå°†é£Ÿç‰©åˆ†è§£ä¸ºå¯å¸æ”¶çš„å°åˆ†å­ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzYyNDMwNjg3Nw==&amp;mid=2247484022&amp;idx=1&amp;sn=01686237c49693d570039970b6b2b1d7" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 10 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-å…¬ä¼—å·">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (66æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE309500ï¼šå¯¹å°æ¢ç½‘è¿›è¡Œå•ç»†èƒåˆ†æï¼Œå‘ç°é’å…‰çœ¼æ¨¡å‹ä¸­å­˜åœ¨çº¿ç²’ä½“åŠŸèƒ½éšœç¢ï¼Œè€Œç»´ç”Ÿç´ B3æ²»ç–—å¯ä¿æŠ¤è¯¥åŠŸèƒ½ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€oncologyã€carcinomaã€leukemiaã€immuneã€immunityã€TMEã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€proteomeã€proteomicsã€Bioconductorã€Seuratã€Scanpyã€epigeneticã€epigenomeã€methylationã€histoneã€enrichmentã€clustering<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Revathi Balasubramanian ; Taibo Li ; Guorong LiSeries Type : Genome binding/occupancy profiling by high throughput sequencing ; Expression profiling by high throughput sequencingOrganism : Mus musculusSince the trabecular meshwork (TM) is central to intraocular pressure (IOP) regulation and glaucoma, a deeper understanding of its genomic landscape is needed. We present a multimodal, single-cell resolution analysis of mouse limbal cells (includes TM). In total, we sequenced 9,394 wild-type TM cell transcriptomes. We discovered three TM cell subtypes with characteristic signature genes validated by immunofluorescence on tissue sections and whole-mounts. The subtypes are robust, being detected in datasets for two diverse mouse strains and in independent data from two institutions. Results show compartmentalized enrichment of critical pathways in specific TM cell subtypes. Distinctive signatures include increased expression of genes responsible for 1) extracellular matrix structure and metabolism (TM1 subtype), 2) secreted ligand signaling to support Schlemmâ€™s canal cells (TM2), and 3) contractile and mitochondrial/metabolic activity (TM3). ATAC-sequencing data identified active transcription factors in TM cells, including LMX1B. Mutations in LMX1B cause high IOP and glaucoma. LMX1B is emerging as a key transcription factor for normal mitochondrial function and its expression is much higher in TM3 cells than other limbal cells. To understand the role of LMX1B in TM function and glaucoma, we single-cell sequenced limbal cells from Lmx1bV265D/+ mutant mice (2,491 TM cells). In V265D/+ mice, TM3 cells were uniquely affected by pronounced mitochondrial pathway changes. Mitochondria in TM cells of V265D/+ mice are swollen with a reduced cristae area, further supporting a role for mitochondrial dysfunction in the initiation of IOP elevation in these mice. Importantly, treatment with vitamin B3 (nicotinamide), to enhance mitochondrial function and metabolic resilience, significantly protected Lmx1b mutant mice from IOP elevation.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309500" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE275609 æ”¾å°„æ€§è¯ç‰©+æ£€æŸ¥ç‚¹é˜»æ–­æ²»ç–—åçš„è‚¿ç˜¤å…ç–«åŠ›éšæ²»ç–—é¡ºåºã€æ”¾å°„æ€§åŒä½ç´ å’Œè‚¿ç˜¤å…ç–«åŸæ€§è€Œå˜åŒ–</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€oncologyã€leukemiaã€immuneã€immunityã€immunologyã€TMEã€cardiacã€gliomaã€kinaseã€DepMapã€depmapã€sequencingã€RNAseqã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€genomeã€genomicsã€transcriptomeã€proteomeã€R packageã€Seuratã€Scanpyã€histoneã€pathwayã€enrichmentã€clustering<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Mus musculusRadiopharmaceutical therapy (RPT) enhances tumor response to immune checkpoint inhibitors (ICI) in preclinical models, but the effects of different radioisotopes have not been compared. To evaluate mechanisms of response to RPT+ICI, we used NM600, an alkylphosphocholine selectively taken up by most tumors. Effects of 90Y-, 177Lu-, and 225Ac-NM600 + ICIs were compared in syngeneic murine models, B78 melanoma (poorly immunogenic) and MC38 colorectal cancer (immunogenic). 90Y-/177Lu-/or 225Ac-NM600 delivering 2 Gy mean tumor dose promoted tumor regression and improved survival when combined with ICIs in syngeneic mice bearing B78 or MC38 tumors. Regardless of the administered isotope, this combination was optimized with early ICI administration (days -3/0/3) relative to day 1 RPT. 90Y-NM600+ICI produced the greatest anti-tumor response for MC38, whereas high linear energy transfer (LET) alpha particle radiation from 225Ac-NM600+ICI was most effective against poorly immunogenic B78 tumors. Flow cytometry and single cell RNA and T cell receptor (TCR) sequencing illuminated distinct mechanisms of 90Y- or 177Lu-NM600 in promoting expansion of existing adaptive immunity and of 225Ac-NM600 in promoting immune priming when combined with ICI. Antitumor immune response can be achieved with appropriate application of Î±- or Î²- emitting RPT in combination with ICIs in diverse murine tumor models.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275609" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE220699 åŸºäºå•ç»†èƒRNAæµ‹åºæŠ€æœ¯ç­›é€‰ç‰¹å®šç”Ÿç‰©æ ‡å¿—ç‰©å¹¶ç ”ç©¶å¸å…¥æ€§æŸä¼¤ï¼ˆILIï¼‰å’Œåˆ›ä¼¤æ€§è‚ºæŸä¼¤ï¼ˆTLIï¼‰çš„å…ç–«è°ƒèŠ‚æœºåˆ¶</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€oncologyã€carcinomaã€immuneã€immunityã€immunologyã€TMEã€metabolicã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€sequencingã€RNAseqã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€bioinformaticsã€Bioconductorã€Seuratã€epigeneticã€epigenomeã€methylationã€histoneã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Chenru Wei ; Zong Shen ; Guosheng Wu ; Tao Tang ; Wenjia Hou ; Banghui Zhu ; Yu SunSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensTo profile the circulating immunological traits of patients with traumatic lung injury (TLI) and inhalation injury (ILI),providing a new direction for the depth research of the pathogenesis, and providing new immune-related targets for diagnosis of the severity of lung injury and treatment, we performed scRNA-seq of neutrophil and PBMCs from fresh circulating blood from 3 patients with TLI and 3 patients with ILI at longitudinal timepoints,as well as peripheral blood from 3 health controls(HCs).We conclude that at different stages of the course of TLI or ILI, there are differences in the proportion of immune cell subsets. PMN function is disordered in the acute stage and the progressive stage, and immature neutrophil subsets of different degrees appear which indicates acute myeloid cells are generated. At the same time, the interactions among the subpopulations of myeloid cells are significantly enhanced during the acute phase, which synergistically promote the development of TLI or ILI.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE220699" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE271957 3DæŸ“è‰²è´¨å˜å¼‚åŸºå› å›¾è°±è·¨è¶Š57ç§äººç±»ç»†èƒç±»å‹æ­ç¤ºè‡ªèº«å…ç–«ç–¾ç—…æ˜“æ„Ÿæ€§çš„ç»†èƒå’Œé—ä¼ ç»“æ„[RNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immuneã€immunityã€TMEã€cardiacã€gliomaã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€methylationã€histoneã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Khanh B Trang ; Megan K Levings ; Struan F Grant ; Andrew D WellsSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThe genetic basis for many common autoimmune disorders has been uncovered by genome-wide association studies (GWAS), but GWAS do not reveal causal variants, effector genes, or the cell types impacted by disease-associated variation. We have generated 3D genomic datasets consisting of promoter-focused Capture-C, Hi-C, ATAC-seq, and RNA-seq and integrated these data with GWAS of 16 autoimmune traits to physically map disease-associated variants to the genes they likely regulate in over 50 human cell types. These 3D maps of gene cis-regulatory architecture are highly powered to identify the cell types most likely impacted by disease-associated genetic variation compared to 1D genomic features, and tend to implicate different effector genes than eQTL approaches in the same cell types. Most of the variants implicated by these cis-regulatory architectures are highly trait-specific, but nearly half of the target genes connected to these variants are shared across multiple autoimmune disorders in multiple cell types, suggesting a high level of genetic diversity and complexity among autoimmune diseases that nonetheless converge at the level of target gene and cell type. Substantial effector gene sharing led to common enrichment of similar biological networks across disease and cell type, however, trait-specific pathways representing potential areas for disease-specific intervention were identified. To test this, we functionally validated squalene synthase, a cholesterol biosynthetic enzyme encoded by the FDFT1 gene implicated in MS and SLE, as a novel immunomodulatory drug target controlling inflammatory cytokine production by human T cells. These data represent a comprehensive resource for basic discovery of gene cis-regulatory mechanisms, and the analyses reported reveal mechanism by which autoimmune-associated variants act to regulate gene expression, function, and pathology across multiple, distinct tissues and cell types.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271957" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE272120 3DæŸ“è‰²è´¨å˜å¼‚åŸºå› å›¾è°±è·¨è¶Š57ç§äººç±»ç»†èƒç±»å‹æ­ç¤ºè‡ªèº«å…ç–«ç–¾ç—…æ˜“æ„Ÿæ€§çš„ç»†èƒå’Œé—ä¼ ç»“æ„[ATAC-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immuneã€immunityã€TMEã€cardiacã€gliomaã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€methylationã€histoneã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Khanh B Trang ; Megan K Levings ; Struan F Grant ; Andrew D WellsSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensThe genetic basis for many common autoimmune disorders has been uncovered by genome-wide association studies (GWAS), but GWAS do not reveal causal variants, effector genes, or the cell types impacted by disease-associated variation. We have generated 3D genomic datasets consisting of promoter-focused Capture-C, Hi-C, ATAC-seq, and RNA-seq and integrated these data with GWAS of 16 autoimmune traits to physically map disease-associated variants to the genes they likely regulate in over 50 human cell types. These 3D maps of gene cis-regulatory architecture are highly powered to identify the cell types most likely impacted by disease-associated genetic variation compared to 1D genomic features, and tend to implicate different effector genes than eQTL approaches in the same cell types. Most of the variants implicated by these cis-regulatory architectures are highly trait-specific, but nearly half of the target genes connected to these variants are shared across multiple autoimmune disorders in multiple cell types, suggesting a high level of genetic diversity and complexity among autoimmune diseases that nonetheless converge at the level of target gene and cell type. Substantial effector gene sharing led to common enrichment of similar biological networks across disease and cell type, however, trait-specific pathways representing potential areas for disease-specific intervention were identified. To test this, we functionally validated squalene synthase, a cholesterol biosynthetic enzyme encoded by the FDFT1 gene implicated in MS and SLE, as a novel immunomodulatory drug target controlling inflammatory cytokine production by human T cells. These data represent a comprehensive resource for basic discovery of gene cis-regulatory mechanisms, and the analyses reported reveal mechanism by which autoimmune-associated variants act to regulate gene expression, function, and pathology across multiple, distinct tissues and cell types.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272120" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE309754 é…ªæ°¨é…¸æ¿€é…¶æŠ‘åˆ¶å‰‚å¿ƒè„æ¯’æ€§çš„å¤šå°ºåº¦åˆ†ææ­ç¤ºæœºæ¢°æ•æ„Ÿç¦»å­é€šé“ PIEZO1 å…·æœ‰å¿ƒè„ä¿æŠ¤ä½œç”¨ [snMultiome]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€TMEã€metabolismã€metabolicã€metabolomeã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€transcriptomeã€proteomeã€proteomicsã€Seuratã€epigeneticã€epigenomeã€methylationã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Nazish Sayed ; Yu LiuSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusTyrosine kinase inhibitors (TKIs) have improved cancer outcomes but are limited by cardiovascular toxicity, most notably hypertension and heart failure. The underlying mechanisms remain poorly understood, hindering the development of protective strategies. Here, we investigated the role of endothelial mechanotransduction in mediating vascular and cardiac injury caused by the VEGFR-targeting TKI sunitinib. Using patient-specific induced pluripotent stem cell-derived endothelial cells (iPSC-ECs) and a mouse model of TKI-induced hypertension, we identified downregulation of PIEZO1, a mechanically activated ion channel, as a central driver of endothelial dysfunction. Restoring PIEZO1 expression, either pharmacologically with Yoda1, a selective agonist, or through inducible overexpression in iPSC-ECs, reversed sunitinib-induced endothelial dysfunction and mitigated its hypertensive effects, providing both mechanistic and genetic validation of PIEZO1â€™s protective role against vascular toxicity. In mice, Yoda1 co-treatment prevented the long-term cardiac dysfunction observed following sunitinib exposure, and normalized elevations in circulating cardiac stress biomarkers. Single-nuclei multiomic profiling of mouse hearts revealed that sunitinib exposure activated chromatin remodeling and fibrogenic programs, which were reversed with PIEZO1 activation. Human engineered cardiac organoids further demonstrated that sunitinib impaired cardiomyocyte function only in the presence of endothelial cells, confirming a role for disrupted endothelial-cardiomyocyte crosstalk in TKI cardiotoxicity. Together, these findings identify endothelial PIEZO1 as a critical mediator of TKI-induced hypertension and cardiac dysfunction and highlight PIEZO1 activation as a potential therapeutic strategy for protecting cardiovascular health during cancer therapy.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309754" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>GSE272080 3DæŸ“è‰²è´¨å˜å¼‚åŸºå› å›¾è°±è·¨è¶Š57ç§äººç±»ç»†èƒç±»å‹æ­ç¤ºè‡ªèº«å…ç–«ç–¾ç—…æ˜“æ„Ÿæ€§çš„ç»†èƒå’Œé—ä¼ ç»“æ„[captureC]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immuneã€immunityã€TMEã€cardiacã€gliomaã€TCGAã€DepMapã€depmapã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€proteomeã€Seuratã€Scanpyã€methylationã€histoneã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Khanh B Trang ; Megan K Levings ; Struan F Grant ; Andrew D WellsSeries Type : OtherOrganism : Homo sapiensThe genetic basis for many common autoimmune disorders has been uncovered by genome-wide association studies (GWAS), but GWAS do not reveal causal variants, effector genes, or the cell types impacted by disease-associated variation. We have generated 3D genomic datasets consisting of promoter-focused Capture-C, Hi-C, ATAC-seq, and RNA-seq and integrated these data with GWAS of 16 autoimmune traits to physically map disease-associated variants to the genes they likely regulate in over 50 human cell types. These 3D maps of gene cis-regulatory architecture are highly powered to identify the cell types most likely impacted by disease-associated genetic variation compared to 1D genomic features, and tend to implicate different effector genes than eQTL approaches in the same cell types. Most of the variants implicated by these cis-regulatory architectures are highly trait-specific, but nearly half of the target genes connected to these variants are shared across multiple autoimmune disorders in multiple cell types, suggesting a high level of genetic diversity and complexity among autoimmune diseases that nonetheless converge at the level of target gene and cell type. Substantial effector gene sharing led to common enrichment of similar biological networks across disease and cell type, however, trait-specific pathways representing potential areas for disease-specific intervention were identified. To test this, we functionally validated squalene synthase, a cholesterol biosynthetic enzyme encoded by the FDFT1 gene implicated in MS and SLE, as a novel immunomodulatory drug target controlling inflammatory cytokine production by human T cells. These data represent a comprehensive resource for basic discovery of gene cis-regulatory mechanisms, and the analyses reported reveal mechanism by which autoimmune-associated variants act to regulate gene expression, function, and pathology across multiple, distinct tissues and cell types.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272080" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> â­ <strong>GSE297038 æ”¾åŒ–ç–—é‡ç¼–ç¨‹å®«é¢ˆç™Œè‚¿ç˜¤ç»†èƒå’Œå…ç–«å¾®ç¯å¢ƒ [æ‰¹é‡ RNA æµ‹åº]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€immuneã€tumor microenvironmentã€TMEã€cardiacã€gliomaã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Tito A Sandoval ; Yize Li ; Naoshad Muhammad ; Tresha Desai ; Reyka Jayasinghe ; Saman Zeeshan ; Kay Jayachandran ; Matthew Inkman ; Michael R Waters ; Naomi Msengi ; Tyler Mckinnish ; Ibrahim Hatipoglu ; Ana C Paschoalini Mafra ; Muyassar Anwar ; Donghua Hu ; Dhaval Bhatt ; Varintra Lander ; R. Jay Mashl ; Liyun Chen ; Jessika Contreras ; Clifford Robinson ; Sherri R Davies ; Julie Belmar ; Shunqiang Li ; M. Benjamin Major ; David G DeNardo ; Stephanie Markovina ; Brian T Edelson ; Jin Zhang ; Li Ding ; Julie K SchwarzSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensDespite advances in screening and prevention, cervical cancer remains a leading cause of cancer-related deaths worldwide, underscoring the need for better treatments. Here, we present a multi-cohort longitudinal study of human cervical tumors and the tumor microenvironment during chemoradiation therapy (CRT). Integrating RNA sequencing, single-cell transcriptomics, and in vivo validation, we define the cellular and molecular programs shaping cell interactions and document how CRT alters them. We identify multiple therapeutic targets in CRT-resistant tumors, notably MDM2, a key mediator of radiation responses in tumor and immune cells. MDM2 inhibition enhanced radiotherapy effects in HPV-positive, TP53 wild-type cervical cancer cells, improved radiation response and reshaped the immune landscape in preclinical models. These findings highlight the potential of combining MDM2 inhibition with CRT to overcome resistance and improve patient outcomes. Our data provides novel insights into therapy-induced changes in tumor and immune compartments, guiding new strategies against treatment-resistant HPV-positive cancers.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297038" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> â­ <strong>GSE272172 3DæŸ“è‰²è´¨å˜å¼‚åŸºå› å›¾è°±è·¨è¶Š57ç§äººç±»ç»†èƒç±»å‹æ­ç¤ºè‡ªèº«å…ç–«ç–¾ç—…æ˜“æ„Ÿæ€§çš„ç»†èƒå’Œé—ä¼ ç»“æ„[HiC]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immuneã€immunityã€TMEã€cardiacã€gliomaã€TCGAã€DepMapã€depmapã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€proteomeã€Seuratã€Scanpyã€methylationã€histoneã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Khanh B Trang ; Struan F Grant ; Andrew D WellsSeries Type : OtherOrganism : Homo sapiensThe genetic basis for many common autoimmune disorders has been uncovered by genome-wide association studies (GWAS), but GWAS do not reveal causal variants, effector genes, or the cell types impacted by disease-associated variation. We have generated 3D genomic datasets consisting of promoter-focused Capture-C, Hi-C, ATAC-seq, and RNA-seq and integrated these data with GWAS of 16 autoimmune traits to physically map disease-associated variants to the genes they likely regulate in over 50 human cell types. These 3D maps of gene cis-regulatory architecture are highly powered to identify the cell types most likely impacted by disease-associated genetic variation compared to 1D genomic features, and tend to implicate different effector genes than eQTL approaches in the same cell types. Most of the variants implicated by these cis-regulatory architectures are highly trait-specific, but nearly half of the target genes connected to these variants are shared across multiple autoimmune disorders in multiple cell types, suggesting a high level of genetic diversity and complexity among autoimmune diseases that nonetheless converge at the level of target gene and cell type. Substantial effector gene sharing led to common enrichment of similar biological networks across disease and cell type, however, trait-specific pathways representing potential areas for disease-specific intervention were identified. To test this, we functionally validated squalene synthase, a cholesterol biosynthetic enzyme encoded by the FDFT1 gene implicated in MS and SLE, as a novel immunomodulatory drug target controlling inflammatory cytokine production by human T cells. These data represent a comprehensive resource for basic discovery of gene cis-regulatory mechanisms, and the analyses reported reveal mechanism by which autoimmune-associated variants act to regulate gene expression, function, and pathology across multiple, distinct tissues and cell types.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272172" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> â­ <strong>GSE279819 æ•²ä½ MSLN é€šè¿‡è°ƒèŠ‚è‚¿ç˜¤å¾®ç¯å¢ƒå¢å¼ºæŠ— PD-1 ç–—æ³•åœ¨é«˜çº§åˆ«æµ†æ¶²æ€§åµå·¢ç™Œä¸­çš„ç–—æ•ˆã€‚[ç»†èƒç³»]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€tumor microenvironmentã€TMEã€cardiacã€gliomaã€kinaseã€TCGAã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€genomeã€genomicsã€proteomeã€Seuratã€Scanpyã€epigeneticã€epigenomeã€methylationã€histoneã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jiaqi Lu ; Haiou Liu ; Yujing Zhong ; Yiying Wang ; Chenyang WangSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe role of MSLN in remodulating tumor microenviroment in high-grade serous ovarian cancer and the underlying mechanisms<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279819" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 56 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ”¬ æœŸåˆŠæ–‡ç«  (5æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨5æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>ä¸åŒç³–å°¿ç—…ç±»å‹å’Œèƒ°è…ºå¯¼ç®¡è…ºç™Œï¼šå­Ÿå¾·å°”éšæœºåŒ–å’Œé€šè·¯/åŸºå› é›†åˆ†æ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šé€šè·¯<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: èƒŒæ™¯ ä¸åŒç±»å‹ç³–å°¿ç—…ï¼ˆä»¥ä¸åŒçš„ç—…ç†ç”Ÿç†å­¦å’Œé—ä¼ ç»“æ„ä¸ºç‰¹å¾ï¼‰ä¸èƒ°è…ºå¯¼ç®¡è…ºç™Œ ï¼ˆPDACï¼‰ é£é™©ä¹‹é—´çš„å…³è”å°šä¸æ¸…æ¥šã€‚æ–¹æ³• ç ”ç©¶ 2 å‹ç³–å°¿ç—…ï¼ˆT2Dï¼‰ã€8 ä¸ª T2D æœºåˆ¶ç°‡ã€1 å‹ç³–å°¿ç—…ï¼ˆT1Dï¼‰å’Œå¹´è½»äººæˆç†ŸæœŸç³–å°¿ç—…ï¼ˆMODYï¼‰çš„é—ä¼ æ˜“æ„Ÿæ€§ä¸ PDAC é£é™©çš„å…³è”ã€‚æˆ‘ä»¬å¯¹æ¬§æ´²è¡€ç»Ÿä¸ªä½“çš„ T2Dï¼ˆ242,283 ä¾‹ï¼Œ1,569,734 ä¾‹ï¼‰ã€T1Dï¼ˆ18,942 ä¾‹ï¼Œ501,638 ä¾‹å¯¹ç…§ï¼‰å’Œ PDACï¼ˆ10,244 ä¾‹å’Œ 360,535 ä¾‹å¯¹ç…§ï¼‰ä½¿ç”¨äº†å…¨åŸºå› ç»„å…³è”ç ”ç©¶ ï¼ˆGWASï¼‰ æ±‡æ€»æ°´å¹³ç»Ÿè®¡ã€‚ç»“æœ é‡‡ç”¨ç¨³å¥è°ƒæ•´æ¦‚å†µè¯„åˆ†ï¼ˆMR-RAPSï¼‰æ–¹æ³•è¿›è¡ŒåŒæ ·æœ¬å­Ÿå¾·å°”éšæœºåŒ–ï¼ˆMRï¼‰ç»“æœæ˜¾ç¤ºï¼Œé—ä¼ é¢„æµ‹çš„ T2D ä¸ PDAC é£é™©ï¼ˆOR = 1.10;95% CI 1.05â€“1.15ï¼‰ç›¸å…³ï¼Œå°¤å…¶æ˜¯ T2D è‚¥èƒ–ï¼ˆOR = 1.28;95% CI 1.15â€“1.42ï¼‰å’Œè„‚è‚ªè¥å…»ä¸è‰¯ï¼ˆOR = 1.25;95%<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1987993557389127680/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>ä¼˜åŒ–è‚¿ç˜¤è¯ç‰©å¼€å‘ï¼š22å¹´éª¨é«“ç˜¤éšæœºå¯¹ç…§è¯•éªŒçš„ç³»ç»Ÿè¯„ä»·</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: å¼•è¨€ å°½ç®¡éª¨é«“ç˜¤ä»£è¡¨äº†è‚¿ç˜¤å­¦çš„ä¸€ä¸ªå…³é”®æˆåŠŸæ¡ˆä¾‹ï¼Œä½†å°½ç®¡æ—©æœŸæ´»æ€§è‰¯å¥½ï¼Œä½†ä¸€äº›è¯ç‰©æœªèƒ½è¾¾åˆ°éšæœºå¯¹ç…§è¯•éªŒ ï¼ˆrandomized controlled trialsï¼Œ RCTï¼‰ çš„ä¸»è¦ç»ˆç‚¹ã€‚è¯¥åˆ†ææ—¨åœ¨äº†è§£å¢åŠ éª¨é«“ç˜¤éšæœºå¯¹ç…§è¯•éªŒä¸­è¾¾åˆ°ä¸»è¦ç»ˆç‚¹å¯èƒ½æ€§çš„å› ç´ ã€‚æ–¹æ³• ä½¿ç”¨ MEDLINEã€PubMedã€Embase å’Œ Cochrane Registry ç¡®å®šæˆªè‡³ 2023 å¹´ 10 æœˆå‘è¡¨çš„éª¨é«“ç˜¤éšæœºå¯¹ç…§è¯•éªŒã€‚ç ”ç©¶è¢«åˆ†ä¸ºå¤´å¯¹å¤´ï¼ˆç”¨ä¸€ç§æ–¹æ¡ˆä»£æ›¿å¦ä¸€ç§æ–¹æ¡ˆï¼‰æˆ–é™„åŠ ç–—æ³•ï¼ˆåœ¨ç°æœ‰æ–¹æ¡ˆä¸­æ·»åŠ ä¸€ç§è¯ç‰©ï¼‰ã€‚å¦‚æœè¯•éªŒå¯¹ä¸»è¦ç»“å±€å…·æœ‰ç»Ÿè®¡å­¦æ„ä¹‰ï¼Œåˆ™è®¤ä¸ºè¯•éªŒæ˜¯æˆåŠŸçš„ã€‚é€»è¾‘å›å½’ç¡®å®šäº†è¾¾åˆ°è¯•éªŒç»ˆç‚¹çš„é¢„æµ‹å› ç´ ã€‚ç»“æœ å…±çº³å…¥ 123 é¡¹ RCT çš„ 145 ç¯‡æ¯”è¾ƒã€‚åœ¨å¤šå˜é‡åˆ†æä¸­ï¼Œåªæœ‰ä¸¤ä¸ªå› ç´ ä¸è¾¾åˆ°ä¸»è¦ç»ˆç‚¹ç‹¬ç«‹ç›¸å…³ã€‚å—è¯•è€…å¹´é¾„ä¸­ä½æ•°è¶Šé«˜ï¼Œè¾¾åˆ°ä¸»è¦ç»ˆç‚¹çš„å‡ ç‡è¶Šä½ï¼ˆOR/1 å¹´å¢åŠ ï¼Œ0.90,95%CIï¼š0.83-0.98ï¼‰ã€‚æ€»ç”Ÿå­˜æœŸ<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1987993540737740800/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>æ›²å¦¥ç å•æŠ— Deruxtecan ï¼ˆT-DXdï¼‰ é€šè¿‡ HER2 è¡¨è¾¾å’Œç»“åˆä¸§å¤±äº§ç”Ÿè€è¯æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè€è¯<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: T-DXd å¯¹ HER2 é˜³æ€§å’Œ HER2 ä½è½¬ç§»æ€§ä¹³è…ºç™Œå…·æœ‰ä¸´åºŠç›Šå¤„ã€‚ç„¶è€Œï¼Œéšç€æ—¶é—´çš„æ¨ç§»ï¼Œå¤§å¤šæ•°æ‚£è€…ä¼šå‡ºç°æ²»ç–—è€è¯æ€§ï¼Œè€è¯æœºåˆ¶å®šä¹‰ä¸æ˜ç¡®ã€‚é€šè¿‡å¯¹ T-DXd æ²»ç–—å‰åé…å¯¹æ‚£è€…æ ‡æœ¬çš„åˆ†å­è¡¨å¾ï¼Œæˆ‘ä»¬å‘ç° 49% çš„ç—…ä¾‹åœ¨è¿›å±•æ—¶ HER2 è¡¨è¾¾æ˜¾ç€ä¸‹é™ï¼Œå…¶ä¸­ 52% çš„ç—…ä¾‹è¡¨ç°å‡º HER2 å®Œå…¨ä¸¢å¤±ã€‚ä½¿ç”¨åŒåŸºå› æ¨¡å‹ç³»ç»Ÿï¼Œæˆ‘ä»¬è¯æ˜ HER2 è¡¨è¾¾çš„é™ä½å¯¹åº”äº T-DXd å†…åŒ–çš„å‡å°‘å’Œç”¨äºæŠ‘åˆ¶è‚¿ç˜¤ç”Ÿé•¿çš„è¯ç‰© IC50 çš„æ˜¾ç€å¢åŠ ã€‚æˆ‘ä»¬è¿›ä¸€æ­¥é‰´å®šå¹¶éªŒè¯äº†æ›²å¦¥ç å•æŠ—ç»“åˆç•Œé¢ï¼ˆV597M å’Œ P593Rï¼‰ä¸­ä¿ƒè¿› T-DXd è€è¯æ€§çš„ HER2 çªå˜ã€‚ä½œä¸ºå…‹æœ T-DXd ç»“åˆå’Œå†…åŒ–å—æŸçš„ç­–ç•¥ï¼Œæˆ‘ä»¬æµ‹è¯•äº† T-DXd ä¸ TROP2 å®šå‘ ADC çš„ä½å‰‚é‡ç»„åˆï¼Œå‘ç°è¿™äº›å¯ä»¥æ›´å‡åŒ€åœ°é€’é€ DXd æœ‰æ•ˆè½½è·ï¼Œä»è€Œå…‹æœç”± HER2 ä¸¢å¤±ä»‹å¯¼çš„é˜»åŠ›ã€‚<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1987999846458568704/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>å¤´é¢ˆéƒ¨é³çŠ¶ç»†èƒç™Œçš„æ–°è¾…åŠ©å…ç–«æ²»ç–—ï¼šå½“å‰è¯æ®å’Œæœªæ¥å±•æœ›</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: å¤´é¢ˆéƒ¨é³çŠ¶ç»†èƒç™Œ ï¼ˆHNSCCï¼‰ æ˜¯ä¸€ç§é«˜åº¦ä¾µè¢­æ€§çš„æ¶æ€§è‚¿ç˜¤ã€‚ä¼ ç»Ÿæ²»ç–—æ–¹æ³•å¯¹å±€éƒ¨æ™šæœŸ HNSCC æ‚£è€…ç–—æ•ˆæœ‰é™ï¼Œæ–°è¾…åŠ©å…ç–«æ²»ç–—æˆä¸ºæ–°çš„å¸Œæœ›ã€‚ç„¶è€Œï¼Œç›®å‰æ–°è¾…åŠ©å…ç–«æ²»ç–— HNSCC çš„ç»“æœå°šä¸ç†æƒ³ï¼Œè¿«åˆ‡éœ€è¦æ”¹è¿›ã€‚æœ¬æ–‡å…¨é¢ç»¼è¿°äº†æ–°è¾…åŠ©å…ç–«æ²»ç–—åœ¨ HNSCC æ²»ç–—é¢†åŸŸçš„ä¸´åºŠç ”ç©¶è¿›å±•ã€‚é€šè¿‡ç»¼åˆå…ç–«å¾®ç¯å¢ƒè°ƒæ§æœºåˆ¶çš„è§‚ç‚¹ï¼Œæˆ‘ä»¬æå‡ºäº†æé«˜æ–°è¾…åŠ©å…ç–«æ²»ç–—å¯¹ HNSCC æ‚£è€…ç–—æ•ˆçš„æœªæ¥ç ”ç©¶æ–¹å‘ã€‚<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1988087372061978624/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> <strong>é‡æ–°å®šä¹‰å†œæ‘ï¼šé‡‡ç”¨åŸºäºèº«ä»½å’Œç¤¾åŒºå‚ä¸çš„æ–¹æ³•æ¥å®šä¹‰å†œæ‘ç™Œç—‡å·®å¼‚ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç¾å›½çš„å†œæ‘å¥åº·å·®è·ä»ç„¶çŸ¥ä¹‹ç”šå°‘ï¼Œéƒ¨åˆ†åŸå› æ˜¯â€œå†œæ‘â€çš„å®šä¹‰ä¸ä¸€è‡´ï¼Œä»¥åŠæœªèƒ½æ•´åˆåœ°ç†å’Œç¤¾ä¼šå»ºæ„çš„åœ°æ–¹ç»´åº¦ã€‚æœ¬è¯„è®ºå€Ÿé‰´äº† 2024 å¹´ç¤¾åŒºå’Œå†œæ‘åŒ»ç–—ä¿å¥è½¬å‹ ï¼ˆTCRHï¼‰ ä¼šè®®â€œè§£å†³å†œæ‘ç¤¾åŒºç™Œç—‡é¢„é˜²ã€æ§åˆ¶å’Œç”Ÿå­˜å¤šæ ·æ€§â€å°ç»„è®¨è®ºæœŸé—´åˆ†äº«çš„è§è§£ã€‚å°ç»„æˆå‘˜å¼ºè°ƒäº†å½“å‰åŸä¹¡åˆ†ç±»ç³»ç»Ÿçš„å±€é™æ€§ï¼Œè¿™äº›ç³»ç»Ÿå¾€å¾€å¿½è§†äº†å†œæ‘äººå£çš„äº¤å‰èº«ä»½ã€æ–‡åŒ–å¼‚è´¨æ€§å’Œç”Ÿæ´»ç»å†ã€‚ä»–ä»¬ä¸»å¼ å°†åŸºäºç¤¾åŒºçš„å‚ä¸å¼ç ”ç©¶ ï¼ˆCBPRï¼‰ å’ŒåŸºäºèº«ä»½çš„æ–¹æ³•ç»“åˆèµ·æ¥ï¼Œä»¥æ›´å…¨é¢åœ°å®šä¹‰å†œæ‘ã€‚æ­¤ç±»æ–¹æ³•ä¼˜å…ˆè€ƒè™‘è‡ªæˆ‘è®¤åŒã€å¥åº·çš„ç¤¾ä¼šå†³å®šå› ç´  ï¼ˆSDOHï¼‰ å’Œæœ¬åœ°åŒ–çŸ¥è¯†ï¼Œä»è€Œå¯ä»¥æ›´å‡†ç¡®åœ°è¯„ä¼°ç™Œç—‡å·®å¼‚å¹¶åˆ¶å®šå…¬å¹³çš„å¹²é¢„æªæ–½ã€‚è¯¥è¯„è®ºæ¦‚è¿°äº†åœ°çƒç‰©ç†å’ŒåŸºäºäººå£æ™®æŸ¥çš„æŒ‡æ ‡è™½ç„¶æ–¹ä¾¿ï¼Œä½†å¦‚ä½•æ­ªæ›²å†œæ‘ç¤¾åŒºï¼Œå¹¶æ— æ„ä¸­ä½¿ç™Œç—‡æŠ¤ç†å¯åŠæ€§ã€ç»“æœå’Œæ”¿ç­–æ–¹é¢çš„å·®å¼‚é•¿æœŸå­˜åœ¨ã€‚ä½œè€…ä¸»å¼ ä»¥èº«ä»½å’Œç¤¾åŒºä¸ºä¸­å¿ƒçš„å†œæ‘æ¦‚å¿µåŒ–ï¼Œè¿™ç§æ¦‚å¿µæ˜¯åŠ¨æ€çš„ã€åŒ…å®¹çš„ï¼Œå¹¶å¯¹å†œæ‘ç”Ÿæ´»çš„å¤æ‚æ€§åšå‡ºååº”ã€‚<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1988000556768145408/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡ (1æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨1æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>ä¸€äº›çœ‹ä¼¼æ— ç”¨å´åˆå®ç”¨çš„ R å‡½æ•°â€”â€”åœ¨æ•°å­— Ï€ ä¸­æŸ¥æ‰¾å­å­—ç¬¦ä¸²</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTME<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šThey say that number Pi holds all infinite possibilities, all the words, all the combinations. Well, easier said to be done. So letâ€™s put this to a test. This is my translational table. We will do this in the followingâ€¦Read more â€º Continue reading: Little useless-useful R functions â€“ Finding substrings in number Pi<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/11/little-useless-useful-r-functions-finding-substrings-in-number-pi/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (2æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨2æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>MntJULiP å’Œ Jutils â€“ åŸºäºåå˜é‡çš„ RNA-seq æ•°æ®å·®å¼‚å‰ªæ¥åˆ†æ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTCGAã€RNA-seqã€RNAseqã€DNA-seqã€ATAC-seqã€scRNAã€scATAC<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šUsing RNA sequencing, researchers from Johns Hopkins University developed MntJULiP and Jutils to accurately detect RNA splicing changes influenced by age, sex, and other biological...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/mntjulip-and-jutils-differential-splicing-analysis-of-rna-seq-data-with-covariates/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>å¥³æ€§æ‚£ä¸Šä¸¥é‡æ–°å† åé—ç—‡çš„å‡ ç‡æ˜¯ç”·æ€§çš„ä¸‰å€ï¼šåŸå› å¦‚ä¸‹</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTMEã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers used RNA sequencing to uncover immune, hormonal, and metabolic differences explaining why women with long COVID often experience more severe and persistent symptoms than men...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/women-are-three-times-more-likely-than-men-to-get-severe-long-covid-heres-why/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>TME</td>
<td>62</td>
</tr>
<tr>
<td>scRNA</td>
<td>56</td>
</tr>
<tr>
<td>genome</td>
<td>56</td>
</tr>
<tr>
<td>scDNA</td>
<td>53</td>
</tr>
<tr>
<td>Seurat</td>
<td>52</td>
</tr>
<tr>
<td>glioma</td>
<td>49</td>
</tr>
<tr>
<td>scATAC</td>
<td>48</td>
</tr>
<tr>
<td>TCGA</td>
<td>44</td>
</tr>
<tr>
<td>cancer</td>
<td>38</td>
</tr>
<tr>
<td>genomics</td>
<td>36</td>
</tr>
<tr>
<td>tumor</td>
<td>35</td>
</tr>
<tr>
<td>spatial</td>
<td>32</td>
</tr>
<tr>
<td>cardiac</td>
<td>27</td>
</tr>
<tr>
<td>immune</td>
<td>26</td>
</tr>
<tr>
<td>histone</td>
<td>25</td>
</tr>
<tr>
<td>proteome</td>
<td>24</td>
</tr>
<tr>
<td>RNAseq</td>
<td>21</td>
</tr>
<tr>
<td>DepMap</td>
<td>18</td>
</tr>
<tr>
<td>depmap</td>
<td>18</td>
</tr>
<tr>
<td>single.cell</td>
<td>18</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-å…¬ä¼—å·"></a>ğŸ“° å…¬ä¼—å· å…¶ä»–å†…å®¹ (10æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503930&amp;idx=4&amp;sn=1767c51851d404941197662854064212" target="_blank" rel="noopener noreferrer">æœ€æ–°9.4åˆ†å•åŸºå› çº¯ç”Ÿä¿¡ï¼Œç»å…¸çš„æ€è·¯ä¸ºä½•èƒ½å‘è¡¨è¿™ä¹ˆé«˜åˆ†ï¼Œä½ è¡Œä½ ä¹Ÿä¸Šï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503930&amp;idx=3&amp;sn=6a0cac8379033db41cdf20e6b73c6453" target="_blank" rel="noopener noreferrer">è°è¯´å•åŸºå› æ²¡å‰é€”ï¼Œç»“åˆå•ç»†èƒï¼Œç©ºè½¬å’Œå®éªŒéªŒè¯ï¼Œç…§æ ·å‘8åˆ†1åŒºæ–‡ç« ï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkwMzY2NjkwNg==&amp;mid=2247495506&amp;idx=1&amp;sn=2810e4b1f970d0c2087ff1a8900db795" target="_blank" rel="noopener noreferrer">Science |è¿™ç§å‘ç°æœ‰æ„æ€ï¼Œè‚ç»†èƒç™Œçš„èµ·æºä¸è‚è„ä»£è°¢åˆ†åŒºå¯†åˆ‡ç›¸å…³ï¼Œå…¶ä»–ç™Œç§æ˜¯å¦ä¹Ÿæœ‰è¿™ç§åŒºåŸŸç‰¹æ€§å‘¢ï¼Ÿ</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkxMDY1MjU1OA==&amp;mid=2247488496&amp;idx=1&amp;sn=d8e474f00d0f640153e49bf38a03e7c6" target="_blank" rel="noopener noreferrer">æ–‡çŒ®åˆ†äº« | ã€Natureé‡ç£…å‘å¸ƒã€‘ç©ºé—´ä¸‰ç»„å­¦å…¨æ™¯å¼ç»˜åˆ¶å¤§è„‘å‘è‚²ä¸ç¥ç»ç‚ç—‡åŠ¨æ€å›¾è°±</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247657588&amp;idx=2&amp;sn=ea98057240951d29600d30eb64e7333f" target="_blank" rel="noopener noreferrer">Stem Cell Repï¼šåˆ©ç”¨äººèƒƒç±»å™¨å®˜ç§»æ¤å®ç°èƒƒæºæ€§èƒ°å²›ç´ åˆ†æ³Œç»†èƒçš„ä½“å†…è¯±å¯¼ | Cell Pressè®ºæ–‡é€Ÿé€’</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656509414&amp;idx=3&amp;sn=7ae801cbd1d8f01458191f92c6e25f76" target="_blank" rel="noopener noreferrer">11æœˆ23æ—¥è®ºå›æ—¥ç¨‹ | ç¬¬å…«å±Šä¸Šæµ·å›½é™…è‚¿ç˜¤å†…ç§‘å­¦è®ºå›ï¼ˆ8th SIMOSï¼‰å¤§å’–äº‘é›† é‚€æ‚¨ç›¸èš</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656509414&amp;idx=2&amp;sn=f4922720401ba719f5a0cc93d291d79b" target="_blank" rel="noopener noreferrer">ç›¸çº¦åŒ—äº¬ï¼2025è¡¨è§‚é—ä¼ å‰æ²¿ç†è®ºä¸æ–¹æ³•å­¦æœ¯è®ºå›å°†äº12æœˆ5-6æ—¥å¬å¼€ï¼Œå…è´¹æ³¨å†Œä¸­ï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656509414&amp;idx=1&amp;sn=2eed33d4a3226dd3908b9d9093aa7930" target="_blank" rel="noopener noreferrer">è‚ºç™Œæ²»ç–—æ–°çªç ´ï¼ä¸Šæµ·å¸‚è‚ºç§‘åŒ»é™¢ä»»èƒœç¥¥/é™ˆæ–Œ/è®¸äºšèç­‰æ¶ˆèæœ¯è”åˆå…ç–«ç–—æ³•æ˜¾ç€å»¶é•¿æ™šæœŸè‚ºç™Œæ‚£è€…ç”Ÿå­˜æœŸï¼Œä¸”å®‰å…¨æ€§å¯æ§</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkxODY4NDEwMA==&amp;mid=2247489800&amp;idx=1&amp;sn=d8e2971dffc4903cddab513d537c506a" target="_blank" rel="noopener noreferrer">è½°åŠ¨å…¨çƒï¼è¯ºå¥–å¾—ä¸»å†å‘Natureï¼Œæœ€æ–°æˆæœå…¬å¸ƒï¼Œå…ç–«å­¦é¢†åŸŸè¿æ¥å…¨æ–°é£æš´ï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655821349&amp;idx=2&amp;sn=4a06dc5d104888b7f1f2f1b39d824ebf" target="_blank" rel="noopener noreferrer">å¦‚æœä½ æƒ³ä»ä»£è°¢è§’åº¦ç”³è¯·å›½è‡ªç„¶ï¼Œæ¨èå››ä¸ªé«˜ç«¯æ€è·¯ç»™ä½ â€¦â€¦</a></li>
</ul>
</div>
</details>

<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (56æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297041" target="_blank" rel="noopener noreferrer">GSE297041 æ”¾åŒ–ç–—é‡ç¼–ç¨‹å®«é¢ˆç™Œè‚¿ç˜¤ç»†èƒå’Œå…ç–«å¾®ç¯å¢ƒ [scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283108" target="_blank" rel="noopener noreferrer">GSE283108 PML-mTOR-RONIN æ ¸å¤åˆç‰©åœ¨ä¸‰é˜´æ€§ä¹³è…ºç™Œä¸­å¯¹æ ¸ç³–ä½“åŸºå› è¡¨è¾¾å’Œè¡°è€çš„è°ƒæ§ [ChIP-seq_mTOR]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283107" target="_blank" rel="noopener noreferrer">GSE283107 PML-mTOR-RONIN æ ¸å¤åˆç‰©åœ¨ä¸‰é˜´æ€§ä¹³è…ºç™Œä¸­å¯¹æ ¸ç³–ä½“åŸºå› è¡¨è¾¾å’Œè¡°è€çš„è°ƒæ§ [ChIP-seq_PML]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279226" target="_blank" rel="noopener noreferrer">GSE279226 æ•²ä½ MSLN é€šè¿‡è°ƒèŠ‚è‚¿ç˜¤å¾®ç¯å¢ƒå¢å¼ºæŠ— PD-1 ç–—æ³•åœ¨é«˜çº§åˆ«æµ†æ¶²æ€§åµå·¢ç™Œä¸­çš„ç–—æ•ˆã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297276" target="_blank" rel="noopener noreferrer">GSE297276 æ•´ä½“æˆåƒæ˜¾ç¤ºï¼Œè¡€ç®¡å†…å¢æ®–ä¿ƒè¿›äº†æ–°å‹éšçƒèŒè„‘ä¾µè¢­è¿‡ç¨‹ä¸­å­ç»†èƒçš„è·¨å†…çš®è¿ç§»</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283106" target="_blank" rel="noopener noreferrer">GSE283106 PML-mTOR-RONIN æ ¸å¤åˆç‰©åœ¨ä¸‰é˜´æ€§ä¹³è…ºç™Œä¸­å¯¹æ ¸ç³–ä½“åŸºå› è¡¨è¾¾å’Œè¡°è€çš„è°ƒæ§ [RNA-seq_shPML]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309753" target="_blank" rel="noopener noreferrer">GSE309753 å¤šå°ºåº¦åˆ†æé…ªæ°¨é…¸æ¿€é…¶æŠ‘åˆ¶å‰‚å¿ƒè„æ¯’æ€§æ­ç¤ºæœºæ¢°æ•æ„Ÿæ€§ç¦»å­é€šé“ PIEZO1 å…·æœ‰å¿ƒè„ä¿æŠ¤ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304531" target="_blank" rel="noopener noreferrer">GSE304531 è‚ºç‚åå¹¼é¼ çš„å¹´é¾„ä¾èµ–æ€§å…ç–«ååº”å’Œé©»ç•™ç»†èƒåŠ¨æ€ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266320" target="_blank" rel="noopener noreferrer">GSE266320 é€šè¿‡å•ç»†èƒå¤šè¡¨è§‚åŸºå› ç»„æ•°æ®æ•´åˆæ¡†æ¶é‡å»ºè¡¨è§‚åŸºå› ç»„åŠ¨æ€</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309044" target="_blank" rel="noopener noreferrer">GSE309044 è‚ç»†èƒç™Œçš„èµ·æºå—ä»£è°¢åˆ†åŒºè°ƒæ§ [å•æ ¸åŸºå› åˆ†å‹]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282160" target="_blank" rel="noopener noreferrer">GSE282160 å¤šåŠŸèƒ½åˆ†å­å·¥å…·å¯å®ç°æ¤ç‰©ä¸­å¯å®šåˆ¶çš„DNAç”²åŸºåŒ–ç¼–è¾‘ [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271241" target="_blank" rel="noopener noreferrer">GSE271241 åŸå§‹å¤šèƒ½æ€§çš„é€€å‡ºåŒ…å«ä¸€ä¸ªç”±ä»£è°¢è¯±å¯¼çš„ç«¯ç²’ç¨³æ€æ£€æŸ¥ç‚¹ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308568" target="_blank" rel="noopener noreferrer">GSE308568 è‚ç»†èƒç™Œçš„èµ·æºå—ä»£è°¢åˆ†åŒºè°ƒæ§ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299620" target="_blank" rel="noopener noreferrer">GSE299620 cFLIPæŠ‘åˆ¶ç”±caspase-8 D387Aè‡ªèº«åŠ å·¥å—æŸé©±åŠ¨çš„Caspase-1å’ŒMLKLéä¾èµ–æ€§å›´äº§æœŸè‡´æ­»æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296246" target="_blank" rel="noopener noreferrer">GSE296246 ä¿å®ˆçš„C2H2é”ŒæŒ‡è›‹ç™½Rel1å°†æ ¸ç³–ä½“ç”Ÿç‰©åˆæˆä¸æ™®éå­˜åœ¨çš„äººç±»çœŸèŒç—…åŸä½“çš„æ€§å‘è‚²å’Œç¯å¢ƒåº”æ¿€ååº”è”ç³»èµ·æ¥</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300073" target="_blank" rel="noopener noreferrer">GSE300073 ä¸çŠ¶ç—…æ¯’æ„ŸæŸ“ç ´åäººiPSCè¡ç”Ÿè‚ é“ç±»å™¨å®˜çš„ä¸Šçš®å±éšœåŠŸèƒ½å’Œç¦»å­è½¬è¿</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298600" target="_blank" rel="noopener noreferrer">GSE298600 ä¸çŠ¶ç—…æ¯’æ„ŸæŸ“ç ´åäººiPSCè¡ç”Ÿè‚ é“ç±»å™¨å®˜çš„ä¸Šçš®å±éšœåŠŸèƒ½å’Œç¦»å­è½¬è¿</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282098" target="_blank" rel="noopener noreferrer">GSE282098 è‡ªé—­ç—‡å°‘çªèƒ¶è´¨ç»†èƒå‡è¯´ï¼šä¸»è°ƒæ§åŸºå›  Baf155 çš„ä¸»è¦ä½œç”¨ [ChIP-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275066" target="_blank" rel="noopener noreferrer">GSE275066 åŸºäºRNAæµ‹åºæ•°æ®çš„NAT10æŠ‘åˆ¶å‰‚ï¼ˆé‡å¡‘ç´ ï¼‰å¯¹ä¸˜è„‘å‡ºè¡€æ²»ç–—ä¸­ç‚ç—‡ç›¸å…³åŸºå› çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307131" target="_blank" rel="noopener noreferrer">GSE307131 äººç±»ç™½ç»†èƒä¸­E3æ³›ç´ è¿æ¥é…¶CBLçš„ä½“ç»†èƒç¼ºé™·ä¼šæŸå®³Bç»†èƒè€ŒéTç»†èƒçš„å‘è‚²å’ŒåŠŸèƒ½</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283109" target="_blank" rel="noopener noreferrer">GSE283109 PML-mTOR-RONINæ ¸å¤åˆç‰©åœ¨ä¸‰é˜´æ€§ä¹³è…ºç™Œä¸­å¯¹æ ¸ç³–ä½“åŸºå› è¡¨è¾¾å’Œè¡°è€çš„è°ƒæ§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281598" target="_blank" rel="noopener noreferrer">GSE281598 èƒƒæ—è·¯æ‰‹æœ¯è¯±å¯¼æŒç»­æ€§è‚ é“é€‚åº”å’Œç‹¬ç‰¹çš„ç³–å°¿ç—…ç¼“è§£ç›¸å…³ä»£è°¢åŸºå› è°ƒæ§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282162" target="_blank" rel="noopener noreferrer">GSE282162 å¤šåŠŸèƒ½åˆ†å­å·¥å…·å¯å®ç°æ¤ç‰©ä¸­å¯å®šåˆ¶çš„DNAç”²åŸºåŒ–ç¼–è¾‘ [BiSulfite-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282885" target="_blank" rel="noopener noreferrer">GSE282885 å•ç»†èƒåˆ†ææ­ç¤ºç˜¢ç—•ç–™ç˜©ä¸æ­£å¸¸äººä½“ç»„ç»‡ä¹‹é—´çš„è½¬å½•ç»„å·®å¼‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291344" target="_blank" rel="noopener noreferrer">GSE291344 è½¬å½•å› å­ HHEX å’Œé›„æ¿€ç´ å—ä½“ (AR) é©±åŠ¨å°é¼ è‚¾ä¸Šè…ºæ€§äºŒæ€æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272270" target="_blank" rel="noopener noreferrer">GSE272270 å¹½é—¨èºæ†èŒè¯±å¯¼çš„PPFIA4ä¿ƒè¿›èƒƒç‚å’Œèƒƒç»†èŒå®šæ¤</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308959" target="_blank" rel="noopener noreferrer">GSE308959 è‚ç»†èƒç™Œçš„èµ·æºå—ä»£è°¢åˆ†åŒºè°ƒæ§ [Xenium]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295484" target="_blank" rel="noopener noreferrer">GSE295484 è‚ºç‚åå¹¼é¼ çš„å¹´é¾„ä¾èµ–æ€§å…ç–«ååº”å’Œé©»ç•™ç»†èƒåŠ¨æ€</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE218697" target="_blank" rel="noopener noreferrer">GSE218697 æ­£å¸¸è‘¡è„ç³–è€é‡ (NGT) å’Œå¦Šå¨ æœŸç³–å°¿ç—… (GDM) å­•å¦‡çš„ RNA æµ‹åºæ•°æ®</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308969" target="_blank" rel="noopener noreferrer">GSE308969 è‚ç»†èƒç™Œçš„èµ·æºå—ä»£è°¢åˆ†åŒºè°ƒæ§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE225200" target="_blank" rel="noopener noreferrer">GSE225200 REV-ERBÎ± è°ƒèŠ‚ç‚ç—‡æ€§è‚ ç—…ä¸­çš„è°ƒèŠ‚æ€§ T ç»†èƒåŠŸèƒ½ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282099" target="_blank" rel="noopener noreferrer">GSE282099 è‡ªé—­ç—‡å°‘çªèƒ¶è´¨ç»†èƒå‡è¯´ï¼šä¸»è°ƒæ§åŸºå›  Baf155 çš„ä¸»è¦ä½œç”¨ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE256014" target="_blank" rel="noopener noreferrer">GSE256014 æ¥è‡ªç»†èƒç³»å’Œåˆ†ç¦»çš„å°é¼ å’Œç‰ç±³ç»„ç»‡çš„å•ç»†èƒ RNA æ•°æ®é›†</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255769" target="_blank" rel="noopener noreferrer">GSE255769 å¤šèƒºä¾èµ–æ€§ä»£è°¢å±è”½è°ƒæ§é€‰æ‹©æ€§å‰ªæ¥</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308451" target="_blank" rel="noopener noreferrer">GSE308451 CDK4/6 å’Œ SHP2 ä»‹å¯¼ BRAF/MEK æŠ‘åˆ¶å‰‚åœ¨ 2 ç±»å’Œ 3 ç±» BRAF çªå˜ç™Œç—‡ä¸­çš„è€è¯æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286346" target="_blank" rel="noopener noreferrer">GSE286346 è‚Œè…±å•ç»†èƒæ°´å¹³åŸºå› è¡¨è¾¾è°±åˆ†æï¼ˆæ–°ç”Ÿå„¿æˆ–æˆäººæ ·æœ¬ï¼Œæœ‰æˆ–æ— æŸä¼¤ï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE226454" target="_blank" rel="noopener noreferrer">GSE226454 èƒšçŠ¶ä½“åœ¨ç¼ºæ°§æ¡ä»¶ä¸‹çš„å•ç»†èƒè½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307044" target="_blank" rel="noopener noreferrer">GSE307044 Optineurin å¡‘é€  BV2 å°èƒ¶è´¨ç»†èƒçš„åŸºç¡€è½¬å½•ç»„å’Œ LPS è¯±å¯¼çš„è½¬å½•ç»„</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283595" target="_blank" rel="noopener noreferrer">GSE283595 ç­‰ä½åŸºå› ç‰¹å¼‚æ€§ ApoE é€šè¿‡ Lrp8 ä»‹å¯¼çš„ç¥ç»å…ƒä½œç”¨å¢å¼ºè„Šé«“æŸä¼¤åçš„è½´çªå†ç”Ÿå’ŒåŠŸèƒ½æ¢å¤</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281775" target="_blank" rel="noopener noreferrer">GSE281775 è€å¹´å’Œå¹´è½»å°é¼ å¿ƒè„çš„è½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281772" target="_blank" rel="noopener noreferrer">GSE281772 è€å¹´å’Œå¹´è½»å°é¼ å¿ƒè„çš„è½¬å½•ç»„åˆ†æ [scMulti-ome]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281602" target="_blank" rel="noopener noreferrer">GSE281602 è€å¹´å’Œå¹´è½»å°é¼ å¿ƒè„çš„è½¬å½•ç»„åˆ†æ [RRBS]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248148" target="_blank" rel="noopener noreferrer">GSE248148 é‰´å®šå— Ppp2ca è°ƒæ§çš„æ”¹å˜åŸºå›  [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE218909" target="_blank" rel="noopener noreferrer">GSE218909 æœ‰ç—‡çŠ¶å’Œæ— ç—‡çŠ¶å®¿ä¸»å¯¹æ ¸ç›˜èŒçš„ååº”</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE244943" target="_blank" rel="noopener noreferrer">GSE244943 DPP4æŠ‘åˆ¶å‰‚åœ¨å…¨èº«ç‚ç—‡æœŸé—´ä¿æŠ¤è¡€ç®¡å±éšœå®Œæ•´æ€§ - ç¬¬2æ‰¹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE244815" target="_blank" rel="noopener noreferrer">GSE244815 DPP4æŠ‘åˆ¶å‰‚åœ¨å…¨èº«ç‚ç—‡æœŸé—´ä¿æŠ¤è¡€ç®¡å±éšœå®Œæ•´æ€§ - æ‰¹æ¬¡1</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE225202" target="_blank" rel="noopener noreferrer">GSE225202 REV-ERBÎ± è°ƒèŠ‚ç‚ç—‡æ€§è‚ ç—…ä¸­çš„è°ƒèŠ‚æ€§ T ç»†èƒåŠŸèƒ½ [CUT&amp;RUN]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291736" target="_blank" rel="noopener noreferrer">GSE291736 ç»†èƒå¤– BRICK1 é©±åŠ¨å¿ƒè‚Œæ¢—æ­»åçš„å¿ƒè„ä¿®å¤</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282062" target="_blank" rel="noopener noreferrer">GSE282062 é‚»è¿‘æ ‡è®°æ­ç¤º 14-3-3 è›‹ç™½ YWHAB åœ¨ä¹³è…ºç™Œ CDK4/6 æŠ‘åˆ¶å‰‚è€è¯ä¸­çš„ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248146" target="_blank" rel="noopener noreferrer">GSE248146 è¯†åˆ«å— Ppp2ca åŸºå› å½±å“çš„ä¹™é…°åŒ– H3K27 çš„åŸºå› ç»„å æ®ä½ç‚¹ [CUT&amp;RUN]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291472" target="_blank" rel="noopener noreferrer">GSE291472 Hhex å’Œ AR ç¼ºå¤±å¯¹å°é¼ è‚¾ä¸Šè…ºåŸºå› è¡¨è¾¾çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE225203" target="_blank" rel="noopener noreferrer">GSE225203 REV-ERBÎ± è°ƒèŠ‚ç‚ç—‡æ€§è‚ ç—…ä¸­çš„è°ƒèŠ‚æ€§ T ç»†èƒåŠŸèƒ½</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248147" target="_blank" rel="noopener noreferrer">GSE248147 é‰´å®šåŸºå› ç»„ä¸­çš„ Ppp2ca ç»“åˆä½ç‚¹ [CUT&amp;TAG]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217972" target="_blank" rel="noopener noreferrer">GSE217972 H3K9 ä¸‰ç”²åŸºåŒ–é€šè¿‡æŠ‘åˆ¶ Tfr1 è°ƒæ§ç¥ç»å…ƒé“æ­»äº¡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303411" target="_blank" rel="noopener noreferrer">GSE303411 FSP1 å’Œç»„è›‹ç™½å»ä¹™é…°åŒ–é…¶æŠ‘åˆ¶ç™Œç»†èƒæŒç»­æ€§é“æ­»äº¡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293804" target="_blank" rel="noopener noreferrer">GSE293804 è‚Œç»†èƒä¸­ Deaf1 çš„ ChIP-seq</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-11-11 21:42</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>